Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs Oral Antibiotics for Acute Exacerbation of Chronic Rhinosinusitis
NCT03935828Phase 2Withdrawn
- Sponsor
- Naval Medical Center San Diego
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Nanoparticles, Cyclic Peptides, Antimicrobial Peptides
01
Overview
A Phase 2 trial of mupirocin, vancomycin, tobramycin, levofloxacin, amphotericin B liposomal in chronic rhinosinusitis (CRS), sponsored by Naval Medical Center San Diego. Planned start Jun 2019; status: withdrawn.
02
Drugs
mupirocinvancomycintobramycinlevofloxacinamphotericin B liposomal
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03935828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935828.